Search research articles
Contact Us
Filters
Showing results (41-50 of 112) with videos related to
Page
of 12
Sort By:
Clinical Pharmacology and Therapeutics
|
September 1, 1995
Comparison of chloroguanide and mephenytoin for the in vivo assessment of genetically determined CYP2C19 activity in humans
C Partovian, E Jacqz-Aigrain, A Keundjian, et al.
Clinical Pharmacology and Therapeutics
|
May 1, 1992
Relation between chloroguanide bioactivation to cycloguanil and the genetically determined metabolism of mephenytoin in humans
C Funck-Brentano, O Bosco, E Jacqz-Aigrain, et al.
British Journal of Clinical Pharmacology
|
August 1, 1994
Reproducibility of non-invasive measurement and of short-term variability of blood pressure and heart rate in healthy volunteers
L Dimier-David, N Billon, D Costagliola, et al.
The New England Journal of Medicine
|
February 22, 1990
Propafenone
C Funck-Brentano, H K Kroemer, J T Lee, et al.
European Heart Journal
|
March 20, 2003
Bisoprolol dose-response relationship in patients with congestive heart failure: a subgroup analysis in the cardiac insufficiency bisoprolol study(CIBIS II)
T Simon, M Mary-Krause, C Funck-Brentano, et al.
American Heart Journal
|
November 22, 2001
Predictors of medical events and of their competitive interactions in the Cardiac Insufficiency Bisoprolol Study 2 (CIBIS-2)
C Funck-Brentano, R Lancar, S Hansen, et al.
British Journal of Clinical Pharmacology
|
March 12, 1999
A study of the relative bioavailability of cysteamine hydrochloride, cysteamine bitartrate and phosphocysteamine in healthy adult male volunteers
L Tennezé, V Daurat, A Tibi, et al.
Journal of Cardiovascular Pharmacology
|
November 1, 1993
Pharmacokinetics and platelet antiaggregating effects of beraprost, an oral stable prostacyclin analogue, in healthy volunteers
J L Demolis, A Robert, M Mouren, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1983
Inactivation of cytochrome P-450 by a troleandomycin metabolite. Protective role of glutathione
D Pessayre, M Tinel, D Larrey, et al.
Biochemical Pharmacology
|
January 1, 1984
Protective effect of 16,16-dimethyl prostaglandin E2 on the hepatotoxicity of bromobenzene in mice
C Funck-Brentano, M Tinel, C Degott, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 112) with videos related to
Sort By:
Page
of 12
Clinical Pharmacology and Therapeutics
|
September 1, 1995
Comparison of chloroguanide and mephenytoin for the in vivo assessment of genetically determined CYP2C19 activity in humans
C Partovian, E Jacqz-Aigrain, A Keundjian, et al.
Clinical Pharmacology and Therapeutics
|
May 1, 1992
Relation between chloroguanide bioactivation to cycloguanil and the genetically determined metabolism of mephenytoin in humans
C Funck-Brentano, O Bosco, E Jacqz-Aigrain, et al.
British Journal of Clinical Pharmacology
|
August 1, 1994
Reproducibility of non-invasive measurement and of short-term variability of blood pressure and heart rate in healthy volunteers
L Dimier-David, N Billon, D Costagliola, et al.
The New England Journal of Medicine
|
February 22, 1990
Propafenone
C Funck-Brentano, H K Kroemer, J T Lee, et al.
European Heart Journal
|
March 20, 2003
Bisoprolol dose-response relationship in patients with congestive heart failure: a subgroup analysis in the cardiac insufficiency bisoprolol study(CIBIS II)
T Simon, M Mary-Krause, C Funck-Brentano, et al.
American Heart Journal
|
November 22, 2001
Predictors of medical events and of their competitive interactions in the Cardiac Insufficiency Bisoprolol Study 2 (CIBIS-2)
C Funck-Brentano, R Lancar, S Hansen, et al.
British Journal of Clinical Pharmacology
|
March 12, 1999
A study of the relative bioavailability of cysteamine hydrochloride, cysteamine bitartrate and phosphocysteamine in healthy adult male volunteers
L Tennezé, V Daurat, A Tibi, et al.
Journal of Cardiovascular Pharmacology
|
November 1, 1993
Pharmacokinetics and platelet antiaggregating effects of beraprost, an oral stable prostacyclin analogue, in healthy volunteers
J L Demolis, A Robert, M Mouren, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1983
Inactivation of cytochrome P-450 by a troleandomycin metabolite. Protective role of glutathione
D Pessayre, M Tinel, D Larrey, et al.
Biochemical Pharmacology
|
January 1, 1984
Protective effect of 16,16-dimethyl prostaglandin E2 on the hepatotoxicity of bromobenzene in mice
C Funck-Brentano, M Tinel, C Degott, et al.
Page
of 12